| Copper | Approved Investigational | IDH3A | 3419 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of IDH3A mRNA | 15q25.1 | |
| Copper | Approved Investigational | IDS | 3423 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of IDS mRNA | Xq28 | |
| Copper | Approved Investigational | IER3 | 8870 |
upregulated | Copper results in increased expression of IER3 mRNA | 6p21.33 | |
| Copper | Approved Investigational | IER5 | 51278 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of IER5 mRNA | 1q25.3 | |
| Copper | Approved Investigational | IER5 | 51278 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of IER5 mRNA | 1q25.3 | |
| Copper | Approved Investigational | IFI16 | 3428 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of IFI16 mRNA | 1q23.1 | |
| Copper | Approved Investigational | IFI30 | 10437 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of IFI30 mRNA | 19p13.11 | |
| Copper | Approved Investigational | IFI44 | 10561 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of IFI44 mRNA | 1p31.1 | |
| Copper | Approved Investigational | IFIT1 | 3434 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of IFIT1 mRNA | 10q23.31 | |
| Copper | Approved Investigational | IFIT2 | 3433 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of IFIT2 mRNA | 10q23.31 | |
| Copper | Approved Investigational | IFIT3 | 3437 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of IFIT3 mRNA | 10q23.31 | |
| Copper | Approved Investigational | IFIT3 | 3437 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of IFIT3 mRNA | 10q23.31 | |
| Copper | Approved Investigational | IFITM10 | 402778 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of IFITM10 mRNA | 11p15.5 | |
| Copper | Approved Investigational | IFNGR2 | 3460 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of IFNGR2 mRNA | 21q22.11 | |
| Copper | Approved Investigational | IFRD1 | 3475 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of IFRD1 mRNA | 7q31.1 | |
| Copper | Approved Investigational | IFT57 | 55081 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of IFT57 mRNA | 3q13.12-q13.13 | |
| Copper | Approved Investigational | IGF2-AS | 51214 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of IGF2-AS mRNA | 11p15.5 | |
| Copper | Approved Investigational | IGF2R | 3482 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of IGF2R mRNA | 6q25.3 | |
| Copper | Approved Investigational | IGF2R | 3482 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of IGF2R mRNA | 6q25.3 | |
| Copper | Approved Investigational | IGFBP3 | 3486 |
downregulated | Copper results in decreased expression of IGFBP3 mRNA | 7p12.3 | |
| Copper | Approved Investigational | IGFBP6 | 3489 |
upregulated | [Copper results in increased activity of TP53 protein] which results in increased expression of IGFBP6 mRNA | 12q13.13 | |
| Copper | Approved Investigational | IGFBP7 | 3490 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of IGFBP7 mRNA | 4q12 | |
| Copper | Approved Investigational | IGHA1 | 3493 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of IGHA1 mRNA | 14q32.33 | |
| Copper | Approved Investigational | IKBKG | 8517 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of IKBKG mRNA | Xq28 | |
| Copper | Approved Investigational | IL11 | 3589 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of IL11 mRNA | 19q13.42 | |